scholarly journals A Randomized, Double-blind, Active-controlled Clinical Trial of a Cell Culture-derived Inactivated Trivalent Influenza Vaccine (NBP607) in Healthy Children 6 Months Through 18 Years of Age

2018 ◽  
Vol 37 (6) ◽  
pp. 605-611 ◽  
Author(s):  
Chi Eun Oh ◽  
Ui-Yoon Choi ◽  
Byung Wook Eun ◽  
Taek Jin Lee ◽  
Ki Hwan Kim ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Cell Culture ◽  
Influenza Vaccine ◽  
Controlled Clinical Trial ◽  
Healthy Children ◽  
Double Blind ◽  
Trivalent Influenza Vaccine ◽  
A Cell

Immunogenicity and safety of a cell culture-derived inactivated trivalent influenza vaccine (NBP607): A randomized, double-blind, multi-center, phase 3 clinical trial

Vaccine ◽  
2015 ◽  
Vol 33 (41) ◽  
pp. 5437-5444 ◽  
Author(s):  
Joon Young Song ◽  
Hee Jin Cheong ◽  
Jacob Lee ◽  
Heung Jeong Woo ◽  
Seong-Heon Wie ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Cell Culture ◽  
Influenza Vaccine ◽  
Phase 3 ◽  
Double Blind ◽  
Trivalent Influenza Vaccine ◽  
A Cell

Efficacy, safety, and immunogenicity of a Vero-cell-culture-derived trivalent influenza vaccine: a multicentre, double-blind, randomised, placebo-controlled trial

The Lancet ◽  
2011 ◽  
Vol 377 (9767) ◽  
pp. 751-759 ◽  
Author(s):  
P Noel Barrett ◽  
Gregory Berezuk ◽  
Sandor Fritsch ◽  
Gerald Aichinger ◽  
Mary Kate Hart ◽  
...  
Keyword(s):  
Cell Culture ◽  
Influenza Vaccine ◽  
Vero Cell ◽  
Controlled Trial ◽  
Double Blind ◽  
Vero Cell Culture ◽  
Trivalent Influenza Vaccine

scholarly journals Immunogenicity and safety of a cell culture-based quadrivalent influenza vaccine in adults: A Phase III, double-blind, multicenter, randomized, non-inferiority study

2016 ◽  
Vol 12 (9) ◽  
pp. 2278-2288 ◽  
Author(s):  
Stephan Bart ◽  
Kevin Cannon ◽  
Darrell Herrington ◽  
Richard Mills ◽  
Eduardo Forleo-Neto ◽  
...  
Keyword(s):  
Cell Culture ◽  
Influenza Vaccine ◽  
Phase Iii ◽  
Double Blind ◽  
A Cell ◽  
Quadrivalent Influenza Vaccine

Dose ranging of adjuvant and antigen in a cell culture H5N1 influenza vaccine: Safety and immunogenicity of a phase 1/2 clinical trial

Vaccine ◽  
2010 ◽  
Vol 28 (3) ◽  
pp. 840-848 ◽  
Author(s):  
Wendy Keitel ◽  
Nicola Groth ◽  
Maria Lattanzi ◽  
Michaela Praus ◽  
Anne Katrin Hilbert ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Cell Culture ◽  
Influenza Vaccine ◽  
Phase 1 ◽  
Vaccine Safety ◽  
H5n1 Influenza ◽  
A Cell ◽  
Dose Ranging

scholarly journals Safety and tolerability of a cell culture derived trivalent subunit inactivated influenza vaccine administered to healthy children and adolescents: A Phase III, randomized, multicenter, observer-blind study

Vaccine ◽  
2016 ◽  
Vol 34 (2) ◽  
pp. 230-236 ◽  
Author(s):  
Terry Nolan ◽  
Tawee Chotpitayasunondh ◽  
Maria Rosario Capeding ◽  
Simon Carson ◽  
Shelly David Senders ◽  
...  
Keyword(s):  
Cell Culture ◽  
Influenza Vaccine ◽  
Children And Adolescents ◽  
Blind Study ◽  
Phase Iii ◽  
Healthy Children ◽  
A Cell
Sign in / Sign up

Export Citation Format

Share Document